Details for 2017791485

Up to date per 03.04.2026

Actions

Title / Product Name

SEBELIPASE ALFA ZUR REDUZIERUNG VON LEBERFIBROSE UND BEHANDLUNG VON MORBUS WOLMAN AUF BASIS DES ISHAK-FIBROSEGRADS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017791485

EP Publication Number

3518962

E-Number

1399921

Language

PCT Number

US17053961

Publication Date

07.08.2019 A

09.06.2021 B1

Registration Date

09.06.2021

AT Publication Date

15.06.2021

Application Date

28.09.2017

Registration Number

Priorities

30.09.2016

201662402183 P

10.11.2016

201662420233 P

08.02.2017

201762456511 P

IPC

A61K 38/46 20060101AFI20180406BHEP

Maximum Duration of Protection

28.09.2037

Owner

Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US

Representative

No representatives present

Inventor

QUINN, Anthony21 Fort Hill Ave. Gloucester MA 01930US

GOODMAN, Zachary3300 Gallows Road Falls Church VA 22042US

BURTON, Barbara420 E. Superior Ave. Chicago IL 60611US

RANKIN, Andrew121 Seaport Boulevard Boston MA 02110US

FRIEDMAN, Mark230 Upland Ave. Newton MA 02461US

SONI, Paresh148 Long Wharf Drive Mystic CT 06355US

Information about Fees